Logo
C

Crinetics Pharmaceuticals

412 employees

Our mission is to build the leading endocrine company that consistently pioneers new therapeutics to help patients better control their disease and improve their daily lives. Working to accomplish this mission is how we bring our vision to life. For us, that vision is the best possible therapeutics available to all patients with diseases of the endocrine system. We love how that sounds. And we really can’t wait to know how it feels. Notice of Fraudulent Activity for Job Applicants: Please be aware of fraudulent communications from job posting sites or email. Bad actors may try to impersonate Crinetics’ Talent Acquisition team, and their messages may appear legitimate. We strongly recommend you verify all communications you receive about positions at Crinetics. If you are unsure about a posting or email you receive, please contact us at [email protected].

Investor insights

Funding rounds participated in

$500M sweet spot round size

Investor type

Public Company

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2008

Funding rounds raised

Total raised

$500M

from investors over 1 rounds

C

Crinetics Pharmaceuticals raised $500M on November 8, 2024

FAQ